2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
53
Other
9
NET
5
Endocrine
5
Thoracic
3
Head & Neck
3
Genitourinary
3
Sarcoma
2
Gynecologic
2
CNS
2
Other neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Dermatologic
1
Breast
1
Conditions
Brain Neoplasms
2313
Glioblastoma
2016
Glioma
1402
Central Nervous System Neoplasms
692
Astrocytoma
668
Neuroblastoma
647
Gliosarcoma
480
Oligodendroglioma
405
Neoplasms
405
Breast Neoplasms
327
Medulloblastoma
307
Carcinoma, Non-Small-Cell Lung
256
Meningioma
229
Recurrence
224
Sarcoma
215
Melanoma
207
Neoplasm Metastasis
202
Ependymoma
200
Lung Neoplasms
199
Neurofibromatosis 1
169
Lymphoma
162
Meningeal Carcinomatosis
138
Osteosarcoma
135
Ovarian Neoplasms
132
Wilms Tumor
123
Precursor Cell Lymphoblastic Leukemia-Lymphoma
123
Head and Neck Neoplasms
117
Lymphoma, Non-Hodgkin
116
Diffuse Intrinsic Pontine Glioma
113
Rhabdomyosarcoma
107
Interventions
alectinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Intestinal Diseases
×
CNS
×
Clear all
NCT04755920
2024-05-09
SGM-CBM
Leiden University Medical Center
Phase 2
Unknown
10 enrolled
NCT04644315
2023-08-07
ALpha-T
Hoffmann-La Roche
Phase 2
Terminated
1 enrolled
5 charts